Top

Dr. Christine Allen

Dr. Christine Allen

Dr. Christine Allen is a world-renowned and award-winning researcher, experienced leader and entrepreneur. Dr. Allen is a Full Professor in the Leslie Dan Faculty of Pharm acy at the University of Toronto (U of T) where she has had a stellar 20+ year career as a researcher and entrepreneur. She is a globally renowned expert in drug formulation and development with more than 160 publications to her name and numerous successful collaborations with clinical and industry partners. She is co-founder and former president of Nanovista Inc., a company focused on high-precision, image-guided cancer therapy (featured by Scientific American as one of 10 start-ups changing healthcare). She also served as CSO of a biotech company and regularly collaborates with, and serves as an advisor to biotech and pharmaceutical companies.

During her time at U of T, she has held increasingly senior leadership roles, most recently as inaugural Associate Vice-President and Vice-Provost, Strategic Initiatives (2019 – 2022). She has also held senior leadership roles outside of academia, including most recently as the Vice-President Ecosystem Development at adMare Bioinnovations ( 2022 – 2023, one year leave from U of T). Dr. Allen is active in a range of scientific societies and has served on their boards, and most recently as President of the Controlled Release Society (CRS, 2022 – 2023) and President of the Canadian Society for Pharmaceutical Sciences (CSPS, 2020 – 2022). She also served as a member on the Governing Council of the Natural Sciences and Engineering Research Council of Canada for four years (first term 2018 – 2020; second term 2020 – 2022). She spent 10 years as a journal editor. First, as an Associate Editor at the American Chemical Society journal Molecular Pharmaceutics then as an Associate Editor at the Journal of Controlled Release, and finally as the Editor-in-Chief of the Journal of Controlled Release.

Dr. Allen is a fellow of the American Institute for Medical and Biological Engineering, a fellow of CRS, a fellow of the CSPS and a fellow of the Canadian Academy of Health Sciences.

Follow Dr. Allen on LinkedIn Dr. Christine Allen and Twitter/X @ChristineAllenW.

  • Jul 2014 – present            Full Professor (tenured)

   Leslie Dan Faculty of Pharmacy Cross-Appointment in Department of Chemical Engineering and Applied Chemistry, University of Toronto

  • Jul 2022 – Jul 2023            Vice-President Ecosystem Development

   adMare Bioinnovations (one year leave from University of Toronto)

  • July 2019 – Jun 2022       Associate Vice-President and Vice Provost, Strategic Initiatives

   University of Toronto

  • July 2018 – July 2019        Interim Dean

   Leslie Dan Faculty of Pharmacy, University of Toronto

  • Sep 2013 – June 2015      Interim Associate Dean Graduate Education

   Leslie Dan Faculty of Pharmacy, University of Toronto

  • Jan 2011 – Aug 2012        Interim Associate Dean Academic

   Leslie Dan Faculty of Pharmacy, University of Toronto

  • Jul 2007 – Jul 2014            Associate Professor (tenured)

   Leslie Dan Faculty of Pharmacy Cross-Appointment in Department of Chemical Engineering and Applied Chemistry, University of Toronto

  • Jul 2002 – Jun 2007          Assistant Professor

   Leslie Dan Faculty of Pharmacy, University of Toronto

  • 2002 – 2006                       Associate Director

   Molecular Design and Information Technology Centre, Leslie Dan Faculty of Pharmacy, University of Toronto

  • Mar 2002 – Jun 2002        Assistant Director Materials Research

   Celator Pharmaceuticals Corp.*, Vancouver, Canada *spin-off company from B.C. Cancer Agency

  • May 2001 – Feb 2002       Research Scientist II (IRAP Project Leader)

   Celator Pharmaceuticals Corp., Vancouver, Canada

  • 2023                     Barrier-Breaking Breakthrough Award, Controlled Release Society
  • 2023                     Named one of top 25 healthcare technology executives of Toronto
  • 2021                     American Institute for Medical and Biological Engineering Fellow
  • 2021                     Women in Science Award, Controlled Release Society
  • 2019                     Canadian Academy of Health Sciences Fellow
  • 2019                     Controlled Release Society Fellow
  • 2014 – 2019        GSK Chair in Pharmaceutics and Drug Delivery
  • 2017                     Canadian Society for Pharmaceutical Sciences Fellow
  • 2014                     Gattefosse Canada/CSPS Award in Lipid-Based Drug Delivery
  • 2012                      Jorge Heller Controlled Release Society Best Paper of 2011 Award
  • 2008                     Ontario Research and Commercialization Program Innovation Award
  • 2004 – 2009        Canadian Institutes of Health Research / Rx&D Career Award
  • 2006                     Association of Faculties of Pharmacy of Canada/AstraZeneca New Investigator Research Award
  • 2006                     Canadian Society Pharmaceutical Science/GlaxoSmithKline Early Career Award
  • Dec 2021 – Dec 2023          Past President, Canadian Society for Pharmaceutical Sciences
  • July 2022 – Aug 2023          President, Controlled Release Society
  • 2018 – present                    Member, The Toronto Initiative for Diversity and Excellence
  • 2019 – present                    Founder and Lead, UofT Women in STEM: Leading and Reading Book Club
  • 2022 – present                    Member, Editorial Board, Journal of Controlled Release
  • 2017 – present                    Member, Editorial Board, Advanced Drug Delivery Reviews
  • Jun 2000             Ph.D., Department of Chemistry, McGill University Dean’s Honors List
  • Jun 1995             B.Sc., Department of Biochemistry, University of Ottawa Summa Cum Laude and Dean’s Honors List